| |  |
| |
| Description | The kinase p56lck (509 aa) is a T-lymphocyte-specific member of the Src family of non-receptor protein tyrosine kinase. Lck is a 56 kDa phosphoprotein expressed in variety of lymphoid and non-lymphoid cell lineages. Lck contain myristylation sequence, unique amino-terminal regions, followed by Src homology domains SH3 and SH2, a tyrosine kinase catalytic domain, and C-terminal regulatory domain. Lck associates with the inner face of the plasma membrane through its amino-terminus. This interaction is mediated by both myristic acid and palmitic acid that are bound to the amino terminal glycine and Cys-3 and/or Cys-5. The Unique region of Lck represents the domain possessing the greatest sequence diversity within this group of enzymes. This domain is thought to be involved in the interaction of the Lck with specific cellular proteins including Lck substrate. In T-cells it is known, to mediate association with the cytoplasmic tail of T-cell coreceptors CD4 and CD8a. SH3 (Src homology 3) domain is mainly implicated in the regulation of protein-protein interactions, recognizing proline-rich region found in guanine nucleotide exchange factors and GTPase activating proteins. SH2 (Src homology 2) domain of Lck recognizes phosphorylated tyrosine residues on other proteins thereby facilitating the formation of tyrosine phosphorylation-induced multimeric complexes. The tyrosine kinase domain is the catalytic domain of Lck catalyzing the transfer of the gamma-phosphate from ATP to tyrosine residues on proteins. The catalytic domain contains a site of autophosphorylation (Tyr-394), which plays an important role in regulating the protein kinase activity. A C-terminal regulatory domain is also seen containing the major site of tyrosine phosphorylation in vivo (Tyr-505). Phosphorylation of Csk (C-terminal Src kinase) at Tyr-505 leads to inactivation of Lck. Lck is also activated by oxidative stress. Reoxygenation after hypoxia induces Lck kinase activity. |
| Expression | Expressed in variety of lymphoid and non-lymphoid cell lineages (Breast cancer tissues and other cancers too). |
| Localisation | Cell membrane |
| Function | T-cell development, T-cell activation. |
| Homology | Shares sequence homology with other Src family kinases (Src, Hck, Fyn, Blk, Lyn, Fgr, Yes, and Yrk). |
| Nomenclature | | HGNC | LCK 6524 |
| Entrez_Gene | LCK 3932 lymphocyte-specific protein tyrosine kinase |
| Cards |
|---|
| Atlas | LCKID14ch1p34 |
| GeneCards | LCK |
| Ensembl | LCK [Search_View] ENSG00000182866 [Gene_View] |
| Genatlas | LCK |
| GeneLynx | LCK |
| eGenome | LCK |
| euGene | 3932 |
| Genomic and cartography |
|---|
| GoldenPath | LCK - 1p34.3 chr1:32512299-32524353 + 1p34.3 [Description] (hg18-Mar_2006) |
| Ensembl | LCK - 1p34.3 [CytoView] |
| NCBI | Mapview |
| OMIM | Disease map [OMIM] |
| HomoloGene | LCK |
| Gene and transcription | | Genbank | AA747421 [ ENTREZ ] |
| Genbank | AF228313 [ ENTREZ ] |
| Genbank | AJ865079 [ ENTREZ ] |
| Genbank | AK098027 [ ENTREZ ] |
| Genbank | BC013200 [ ENTREZ ] |
| RefSeq | NM_001042771 [ SRS ] NM_001042771 [ ENTREZ ] |
| RefSeq | NM_005356 [ SRS ] NM_005356 [ ENTREZ ] |
| RefSeq | AC_000044 [ SRS ] AC_000044 [ ENTREZ ] |
| RefSeq | AC_000133 [ SRS ] AC_000133 [ ENTREZ ] |
| RefSeq | NC_000001 [ SRS ] NC_000001 [ ENTREZ ] |
| RefSeq | NT_032977 [ SRS ] NT_032977 [ ENTREZ ] |
| RefSeq | NW_001838577 [ SRS ] NW_001838577 [ ENTREZ ] |
| RefSeq | NW_921351 [ SRS ] NW_921351 [ ENTREZ ] |
| AceView | LCK AceView - NCBI |
| Unigene | Hs.470627 [ SRS ] Hs.470627 [ NCBI ]
HS470627 [ spliceNest ] |
| Fast-db | 12917 (alternative variants) |
| Protein : pattern, domain, 3D structure |
|---|
| SwissProt | P06239 [ SRS] P06239 [ EXPASY ] P06239 [ INTERPRO ] P06239 [ UNIPROT ] |
| Prosite | PS00107 PROTEIN_KINASE_ATP [ SRS ] PS00107 PROTEIN_KINASE_ATP [ Expasy ] |
| Prosite | PS50011 PROTEIN_KINASE_DOM [ SRS ] PS50011 PROTEIN_KINASE_DOM [ Expasy ] |
| Prosite | PS00109 PROTEIN_KINASE_TYR [ SRS ] PS00109 PROTEIN_KINASE_TYR [ Expasy ] |
| Prosite | PS50001 SH2 [ SRS ] PS50001 SH2 [ Expasy ] |
| Prosite | PS50002 SH3 [ SRS ] PS50002 SH3 [ Expasy ] |
| Interpro | IPR000719 Prot_kinase_core [ SRS ] IPR000719 Prot_kinase_core [ EBI ] |
| Interpro | IPR017441 Protein_kinase_ATP_bd_CS [ SRS ] IPR017441 Protein_kinase_ATP_bd_CS [ EBI ] |
| Interpro | IPR000980 SH2 [ SRS ] IPR000980 SH2 [ EBI ] |
| Interpro | IPR001452 SH3 [ SRS ] IPR001452 SH3 [ EBI ] |
| Interpro | IPR001245 Tyr_pkinase [ SRS ] IPR001245 Tyr_pkinase [ EBI ] |
| Interpro | IPR008266 Tyr_pkinase_AS [ SRS ] IPR008266 Tyr_pkinase_AS [ EBI ] |
| CluSTr | P06239 |
| Pfam | PF07714 Pkinase_Tyr [ SRS ] PF07714 Pkinase_Tyr [ Sanger ] pfam07714 [ NCBI-CDD ] |
| Pfam | PF00017 SH2 [ SRS ] PF00017 SH2 [ Sanger ] pfam00017 [ NCBI-CDD ] |
| Pfam | PF00018 SH3_1 [ SRS ] PF00018 SH3_1 [ Sanger ] pfam00018 [ NCBI-CDD ] |
| Smart | SM00252 SH2 [EMBL] |
| Smart | SM00326 SH3 [EMBL] |
| Smart | SM00219 TyrKc [EMBL] |
| Prodom | PD000001 Prot_kinase[INRA-Toulouse] |
| Prodom | P06239 LCK_HUMAN [ Domain structure ] P06239 LCK_HUMAN [ sequences sharing at least 1 domain ] |
| Prodom | PD000001[INRA-Toulouse] |
| Prodom | P06239 LCK_HUMAN [ Domain structure ] P06239 LCK_HUMAN [ sequences sharing at least 1 domain ] |
| Prodom | PD000001[INRA-Toulouse] |
| Prodom | P06239 LCK_HUMAN [ Domain structure ] P06239 LCK_HUMAN [ sequences sharing at least 1 domain ] |
| Blocks | P06239 |
| PDB | 1BHF [ SRS ] 1BHF [ PdbSum ], 1BHF [ IMB ] 1BHF [ RSDB ] |
| PDB | 1BHH [ SRS ] 1BHH [ PdbSum ], 1BHH [ IMB ] 1BHH [ RSDB ] |
| PDB | 1CWD [ SRS ] 1CWD [ PdbSum ], 1CWD [ IMB ] 1CWD [ RSDB ] |
| PDB | 1CWE [ SRS ] 1CWE [ PdbSum ], 1CWE [ IMB ] 1CWE [ RSDB ] |
| PDB | 1FBZ [ SRS ] 1FBZ [ PdbSum ], 1FBZ [ IMB ] 1FBZ [ RSDB ] |
| PDB | 1H92 [ SRS ] 1H92 [ PdbSum ], 1H92 [ IMB ] 1H92 [ RSDB ] |
| PDB | 1IJR [ SRS ] 1IJR [ PdbSum ], 1IJR [ IMB ] 1IJR [ RSDB ] |
| PDB | 1KIK [ SRS ] 1KIK [ PdbSum ], 1KIK [ IMB ] 1KIK [ RSDB ] |
| PDB | 1LCJ [ SRS ] 1LCJ [ PdbSum ], 1LCJ [ IMB ] 1LCJ [ RSDB ] |
| PDB | 1LCK [ SRS ] 1LCK [ PdbSum ], 1LCK [ IMB ] 1LCK [ RSDB ] |
| PDB | 1LKK [ SRS ] 1LKK [ PdbSum ], 1LKK [ IMB ] 1LKK [ RSDB ] |
| PDB | 1LKL [ SRS ] 1LKL [ PdbSum ], 1LKL [ IMB ] 1LKL [ RSDB ] |
| PDB | 1Q68 [ SRS ] 1Q68 [ PdbSum ], 1Q68 [ IMB ] 1Q68 [ RSDB ] |
| PDB | 1Q69 [ SRS ] 1Q69 [ PdbSum ], 1Q69 [ IMB ] 1Q69 [ RSDB ] |
| PDB | 1QPC [ SRS ] 1QPC [ PdbSum ], 1QPC [ IMB ] 1QPC [ RSDB ] |
| PDB | 1QPD [ SRS ] 1QPD [ PdbSum ], 1QPD [ IMB ] 1QPD [ RSDB ] |
| PDB | 1QPE [ SRS ] 1QPE [ PdbSum ], 1QPE [ IMB ] 1QPE [ RSDB ] |
| PDB | 1QPJ [ SRS ] 1QPJ [ PdbSum ], 1QPJ [ IMB ] 1QPJ [ RSDB ] |
| PDB | 1X27 [ SRS ] 1X27 [ PdbSum ], 1X27 [ IMB ] 1X27 [ RSDB ] |
| PDB | 2IIM [ SRS ] 2IIM [ PdbSum ], 2IIM [ IMB ] 2IIM [ RSDB ] |
| PDB | 2OF2 [ SRS ] 2OF2 [ PdbSum ], 2OF2 [ IMB ] 2OF2 [ RSDB ] |
| PDB | 2OF4 [ SRS ] 2OF4 [ PdbSum ], 2OF4 [ IMB ] 2OF4 [ RSDB ] |
| PDB | 2OFU [ SRS ] 2OFU [ PdbSum ], 2OFU [ IMB ] 2OFU [ RSDB ] |
| PDB | 2OFV [ SRS ] 2OFV [ PdbSum ], 2OFV [ IMB ] 2OFV [ RSDB ] |
| PDB | 2OG8 [ SRS ] 2OG8 [ PdbSum ], 2OG8 [ IMB ] 2OG8 [ RSDB ] |
| PDB | 2PL0 [ SRS ] 2PL0 [ PdbSum ], 2PL0 [ IMB ] 2PL0 [ RSDB ] |
| PDB | 3B2W [ SRS ] 3B2W [ PdbSum ], 3B2W [ IMB ] 3B2W [ RSDB ] |
| PDB | 3LCK [ SRS ] 3LCK [ PdbSum ], 3LCK [ IMB ] 3LCK [ RSDB ] |
| HPRD | 01080 |
| Protein Interaction databases |
|---|
| DIP | P06239 |
| IntAct | P06239 |
| Polymorphism : SNP, mutations, diseases |
|---|
| OMIM | 153390 [ map ] |
| GENECLINICS | 153390 |
| SNP | LCK [dbSNP-NCBI] |
| SNP | NM_001042771 [SNP-NCI] |
| SNP | NM_005356 [SNP-NCI] |
| SNP | LCK [GeneSNPs - Utah] LCK] [HGBASE - SRS] |
| HAPMAP | LCK [HAPMAP] |
| COSMIC | LCK [Somatic mutation (COSMIC-CGP-Sanger)] |
| TICdb | LCK [Translocation breakpoints In Cancer] |
| HGMD | LCK |
| General knowledge |
|---|
| Family Browser | LCK [UCSC Family Browser] |
| SOURCE | NM_001042771 |
| SOURCE | NM_005356 |
| SMD | Hs.470627 |
| SAGE | Hs.470627 |
| Enzyme | 2.7.10.2 [ Enzyme-Expasy ] 2.7.10.2 [ Enzyme-SRS ] 2.7.10.2 [ IntEnz-EBI ] 2.7.10.2 [ BRENDA ] 2.7.10.2 [ KEGG ] 2.7.10.2 [ WIT ] |
| GO | nucleotide binding [Amigo] nucleotide binding |
| GO | pericentriolar material [Amigo] pericentriolar material |
| GO | glycoprotein binding [Amigo] glycoprotein binding |
| GO | protein tyrosine kinase activity [Amigo] protein tyrosine kinase activity |
| GO | non-membrane spanning protein tyrosine kinase activity [Amigo] non-membrane spanning protein tyrosine kinase activity |
| GO | protein serine/threonine phosphatase activity [Amigo] protein serine/threonine phosphatase activity |
| GO | protein binding [Amigo] protein binding |
| GO | ATP binding [Amigo] ATP binding |
| GO | cytoplasm [Amigo] cytoplasm |
| GO | cytosol [Amigo] cytosol |
| GO | plasma membrane [Amigo] plasma membrane |
| GO | plasma membrane [Amigo] plasma membrane |
| GO | protein amino acid phosphorylation [Amigo] protein amino acid phosphorylation |
| GO | protein amino acid phosphorylation [Amigo] protein amino acid phosphorylation |
| GO | cellular zinc ion homeostasis [Amigo] cellular zinc ion homeostasis |
| GO | induction of apoptosis [Amigo] induction of apoptosis |
| GO | caspase activation [Amigo] caspase activation |
| GO | intracellular signaling cascade [Amigo] intracellular signaling cascade |
| GO | Ras protein signal transduction [Amigo] Ras protein signal transduction |
| GO | protein C-terminus binding [Amigo] protein C-terminus binding |
| GO | transferase activity [Amigo] transferase activity |
| GO | protein kinase binding [Amigo] protein kinase binding |
| GO | hemopoiesis [Amigo] hemopoiesis |
| GO | T cell differentiation [Amigo] T cell differentiation |
| GO | SH2 domain binding [Amigo] SH2 domain binding |
| GO | response to drug [Amigo] response to drug |
| GO | CD4 receptor binding [Amigo] CD4 receptor binding |
| GO | CD8 receptor binding [Amigo] CD8 receptor binding |
| GO | phosphoinositide 3-kinase binding [Amigo] phosphoinositide 3-kinase binding |
| GO | interspecies interaction between organisms [Amigo] interspecies interaction between organisms |
| GO | membrane raft [Amigo] membrane raft |
| GO | positive regulation of T cell receptor signaling pathway [Amigo] positive regulation of T cell receptor signaling pathway |
| GO | positive regulation of T cell activation [Amigo] positive regulation of T cell activation |
| GO | ATPase binding [Amigo] ATPase binding |
| GO | release of sequestered calcium ion into cytosol [Amigo] release of sequestered calcium ion into cytosol |
| GO | regulation of lymphocyte activation [Amigo] regulation of lymphocyte activation |
| BIOCARTA | Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor [Genes] |
| BIOCARTA | The Co-Stimulatory Signal During T-cell Activation [Genes] |
| BIOCARTA | IL 2 signaling pathway [Genes] |
| BIOCARTA | IL-7 Signal Transduction [Genes] |
| BIOCARTA | T Cell Receptor Signaling Pathway [Genes] |
| BIOCARTA | Lck and Fyn tyrosine kinases in initiation of TCR Activation [Genes] |
| KEGG | Natural killer cell mediated cytotoxicity |
| KEGG | T cell receptor signaling pathway |
| PubGene | LCK |
| TreeFam | LCK |
| CTD | 3932 [Comparative ToxicoGenomics Database] |
| Other databases |
|---|
| Probes |
|---|
| Probe | LCK Related clones (RZPD - Berlin) |
| PubMed |
|---|
| PubMed | 299 Pubmed reference(s) in Entrez |
| Alterations in the expression of pp60c-src and p56lck associated with butyrate-induced differentiation of human colon carcinoma cells. |
| Foss FM, Veillette A, Sartor O, Rosen N, Bolen JB |
| Oncogene research. 1989 ; 5 (1) : 13-23. |
| PMID 2476706 |
| |
| lck suppresses gene expression from various promoters including human T-cell leukemia virus type I promoter. |
| Ohta M, Morita T, Shimotohno K |
| Japanese journal of cancer research : Gann. 1990 ; 81 (5) : 440-444. |
| PMID 2116390 |
| |
| Activation of the Lck tyrosine protein kinase by hydrogen peroxide requires the phosphorylation of Tyr-394. |
| Hardwick JS, Sefton BM |
| Proceedings of the National Academy of Sciences of the United States of America. 1995 ; 92 (10) : 4527-4531. |
| PMID 7538674 |
| |
| Specific deficiency of p56lck expression in T lymphocytes from type 1 diabetic patients. |
| Nervi S, Atlan-Gepner C, Kahn-Perles B, Lecine P, Vialettes B, Imbert J, Naquet P |
| Journal of immunology (Baltimore, Md. : 1950). 2000 ; 165 (10) : 5874-5883. |
| PMID 11067948 |
| |
| Tyrosine kinase p56lck regulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through tyrosine phosphorylation of IkappaBalpha following hypoxia/reoxygenation. |
| Mahabeleshwar GH, Kundu GC |
| The Journal of biological chemistry. 2003 ; 278 (52) : 52598-52612. |
| PMID 14534291 |
| |
| Tyrosine kinase, p56lck-induced cell motility, and urokinase-type plasminogen activator secretion involve activation of epidermal growth factor receptor/extracellular signal regulated kinase pathways. |
| Mahabeleshwar GH, Das R, Kundu GC |
| The Journal of biological chemistry. 2004 ; 279 (11) : 9733-9742. |
| PMID 14699120 |
| |
| Structure and regulation of Src family kinases. |
| Boggon TJ, Eck MJ |
| Oncogene. 2004 ; 23 (48) : 7918-7927. |
| PMID 15489910 |
| |
| Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. |
| Palacios EH, Weiss A |
| Oncogene. 2004 ; 23 (48) : 7990-8000. |
| PMID 15489916 |
| |